The GERD Drugs and Devices market is expected to be valued at USD 6.14 billion in 2027 from USD 5.10 billion in 2019, registering a CAGR of2.3% through the forecast period, according to a recent report by Emergen Research. The rise in the trend of self-medication and increased awareness of GERD are key factors affecting the growth of the market. In addition, rising occurrences of GERD disorders, as well as lifestyle changes, are driving market demand. The expiration of the patent on most medicines paves the way for new medicines over the counter and generic ones.
The latest study unravels the unfavorable impacts of the COVID-19 pandemic on the global GERD Drugs and Devices business sector. According to our expert team, the corona virus outbreak has had an overwhelming impact on the global economic landscape, and consequently, on this business vertical. The pandemic is expected to contribute to the potential downturn of the GERD Drugs and Devices industry substantially. Reportedly, this sector has been financially beleaguered since the COVID-19 lockdown restrictions were put into effect. Hence, the report highlights the financial obstacles that have slowed numerous businesses’ progress in this sector and disrupted the global supply chains.
Competitive Overview:
The global GERD Drugs and Devices market report closely studies the functioning mechanisms of the key companies participating in the global market. These companies are said to be following a slew of business expansion strategies to reinforce their financial positions in this market. As per the report, these companies account for a major portion of the overall GERD Drugs and Devices market share. Therefore, this section of the report emphasizes the principal strategic initiatives led by these companies, including mergers & acquisitions, joint ventures, new business deals, new product launches, collaborations, technological upgradation, and several others.
Key Market Players:
Johnson & Johnson, AstraZeneca PLC, Takeda Pharmaceutical Company Limited, Pfizer Inc., Novartis AG, GlaxoSmithKline Plc, Merck & CO., Inc., Boston Scientific Corporation, Eisai Co., Ltd., and Ironwood Pharmaceuticals, Inc., among others.
Global GERD Drugs and Devices Market Report – Table of Contents:
- Report Overview
1.1 Research Scope
1.2 Key GERD Drugs and Devices market segments
1.3 Target players
1.4 Market analysis by type
1.5 Market analysis by application
1.6 Key learning objectives
1.7 Report timeline
- Global Growth Trends
2.1 Global GERD Drugs and Devices market size
2.2 Latest trends of the GERD Drugs and Devices market by region
2.3 Key corporate trends
- Global GERD Drugs and Devices Market share by key players
3.1 Global GERD Drugs and Devices Market size by manufacturers
3.2 Global GERD Drugs and Devices Market key players
3.3 Products/solutions/services of major players
3.4 New entrants in the GERD Drugs and Devices market
3.5 Mergers, acquisitions, joint ventures, and expansion plans
- Global GERD Drugs and Devices Market by product type
4.1 Global GERD Drugs and Devices Sales by Product
4.2 Global GERD Drugs and Devices by Product Revenue
Download the full GERD Drugs and Devices market description@ https://www.emergenresearch.com/industry-report/gerd-drugs-and-devices-market
Thank you for reading our report. For further details or to inquire about customization, please let us know, and we will offer you the report well-suited to your requirements.
